Federated Hermes’s Avita Medical RCEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-77
Closed -$1.23K 2118
2024
Q1
$1.23K Buy
+77
New +$1.25K ﹤0.01% 1947
2023
Q4
Sell
-697
Closed -$10.2K 2177
2023
Q3
$10.2K Sell
697
-360
-34% -$6.09K ﹤0.01% 1825
2023
Q2
$18K Sell
1,057
-181
-15% -$2.66K ﹤0.01% 1787
2023
Q1
$17.3K Buy
+1,238
New +$13.2K ﹤0.01% 1824

Other funds holding RCEL

Federated Hermes's RCEL Position: Q2 2024 in Review

Federated Hermes sold out of Avita Medical (RCEL) in Q2 2024, closing a stake of 77 shares — an estimated $1.23K sold.

Federated Hermes first reported a position in RCEL in Q1 2023 and held it in 4 quarters. The position peaked at $18K in Q2 2023. 68 funds tracked by Wall St. Rank hold RCEL as of Q2 2024.

  • Federated Hermes reported no remaining Avita Medical position as of Q2 2024 after selling out during the quarter.
  • Federated Hermes sold 77 Avita Medical shares in Q2 2024, an estimated $1.23K.
  • Federated Hermes first reported a position in Avita Medical in Q1 2023 and held it in 4 quarters.
  • Federated Hermes's Avita Medical position peaked at $18K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Avita Medical as of Q2 2024.

Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.